“…In accordance with these results, the APCSC study [5,8] found that the association between HDL-C and CVD risk was consistent across both TC and TG levels, whereas the results of the PSC [6] showed that the association was consistent across non-HDL-C levels. In addition, although insufficient to determine the consistency of the association, 36 out of the total 58 prospective studies identified some evidence of a significant inverse association between HDL-C and CVD risk even when controlling for other lipid risk Table 6 Summary of overall study analyses in men, women, and combined analyses of men and women showing a statistically significant inverse association between HDL-C and all CVD outcomes [55-57,59-61, 65,66,69,70,73,74,76,77,79,80,86,88,91,93, 96,98-103,105,110,112,116] [ 55,57,[67][68][69][70]79,81,88,102,115] [58, [62][63][64]75,82,89,90,92,97,104,107] CHD/CVD mortality Total 21 (2) factors. However, in interpreting these results, it is important to note that the associations between various lipids, with the exception of HDL-C, and CVD risk may be altered when lipid measurements are performed in nonfasting versus fasting patients [159], which may partly explain the variations in the strength of the associations noted in this review.…”